![Jean-Pierre Sommadossi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jean-Pierre Sommadossi
Chief Executive Officer at
ATEA PHARMACEUTICALS, INC.
Net worth: 31 M $ as of 2026-05-30
Profile
Dr. Jean-Pierre Sommadossi is a Chairman at Kezar Life Sciences, Inc., a Chairman, President & Chief Executive Officer at Atea Pharmaceuticals, Inc., a Member-Discovery Council at Harvard Medical School and an Independent Director at ABG Acquisition Corp. I. He is on the Board of Directors at Rafael Pharmaceuticals, Inc., The BioExec Institute, Inc. and ABG Acquisition Corp. I. Dr. Sommadossi was previously employed as a Chairman, President & Chief Executive Officer by Idenix Pharmaceuticals LLC, a Co-Founder by Pharmasset, Inc., a Professor by The University of Alabama at Birmingham, a Fogarty Fellow by Medical College of Virginia, a Fogarty Fellow by National Cancer Institute, and an Advisor by Puretech Health LLC. He also served on the board at Alzheon, Inc. and Kinex Pharmaceuticals, Inc. He received his doctorate degree from the University of Marseille.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-04-23 | 6,633,855 ( 8.29% ) | 31 M $ | 2026-05-30 |
Jean-Pierre Sommadossi active positions
| Companies | Position | Start |
|---|---|---|
| ATEA PHARMACEUTICALS, INC. | Chief Executive Officer | 2012-11-30 |
| ABG ACQUISITION CORP. I | Director/Board Member | 2021-01-31 |
The BioExec Institute, Inc.
 The BioExec Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as network of executives in the life sciences industry | Director/Board Member | 2003-12-31 |
Biothea Pharma, Inc.
 Biothea Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals for allergic reactions & anaphylaxis | Chairman | 2014-12-31 |
Former positions of Jean-Pierre Sommadossi
| Companies | Position | End |
|---|---|---|
| KEZAR LIFE SCIENCES, INC. | Chairman | 2022-05-10 |
Pegaone GmbH
 Pegaone GmbH Information Technology ServicesTechnology Services Provides information technology services | Chairman | 2020-12-31 |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 2020-12-31 |
Cornerstone Pharmaceuticals, Inc.
 Cornerstone Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops anti-cancer drug delivery technology | Director/Board Member | 2020-10-31 |
| ATHENEXPAR | Director/Board Member | 2014-06-30 |
Training of Jean-Pierre Sommadossi
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
73
1st degree connections
17
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 17 |
|---|---|
Cornerstone Pharmaceuticals, Inc.
Cornerstone Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops anti-cancer drug delivery technology | Commercial Services |
Idenix Pharmaceuticals LLC
 Idenix Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for the treatment of human viral and infectious diseases caused by hepatitis | Health Technology |
Athenex, Inc.
 Athenex, Inc. BiotechnologyHealth Technology Develops and commercializes drugs for cancer and immunomodulatory diseases | Health Technology |
Pharmasset, Inc.
 Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Develops drugs to treat viral infections | Health Technology |
Alzheon, Inc.
 Alzheon, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops drugs for neurodegenerative disorders | Health Technology |
Atea Pharmaceuticals, Inc.
 Atea Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes antiviral therapeutics | Health Technology |
Puretech Health LLC
 Puretech Health LLC Investment ManagersFinance PureTech Ventures invests in companies located in the United States. The firm focuses on a broad range of sectors. It provides financing for seed, early and later stage capital requirements. | Finance |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous Conducts research projects & awards grants for cancer research | Miscellaneous |
University of Marseille
 University of Marseille Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medical College of Virginia
 Medical College of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Alabama at Birmingham
 The University of Alabama at Birmingham Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The BioExec Institute, Inc.
The BioExec Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as network of executives in the life sciences industry | Commercial Services |
Kezar Life Sciences, Inc.
 Kezar Life Sciences, Inc. BiotechnologyHealth Technology Discovers and develops therapies targeting protein homeostasis | Health Technology |
Pegaone GmbH
Pegaone GmbH Information Technology ServicesTechnology Services Provides information technology services | Technology Services |
Biothea Pharma, Inc.
Biothea Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals for allergic reactions & anaphylaxis | Health Technology |
ABG Acquisition Corp. I
 ABG Acquisition Corp. I Financial ConglomeratesFinance Operates as a blank check company | Finance |
- Stock Market
- Insiders
- Jean-Pierre Sommadossi
